EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes

Qianchang Wang, Zhe Wang, Minzhe Hu, Fangfeng Liu, Zhengjian Wang

Frontiers in Medicine · 31.07.2025 · 12

DOI: 10.3389/fmed.2025.1623367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 31.07.2025. Verfasst von Qianchang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Shandong First Medical University, Jinan, Shandong, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alcohol-associated liver disease (ALD) is a chronic condition influenced by both genetic and environmental factors. While GWAS has identified ALD-related loci (PNPLA3, MBOAT7, TM6SF2), underlying genetic mechanisms and therapeutic targets remain unclear.

Methods

This study utilized the FinnGen R12 dataset (488,982 participants) and GTEx v8 eQTL data to perform a cross-tissue transcriptome-wide association study (TWAS) using UTMOST, with single-tissue validation via FUSION. Gene-level association analysis (MAGMA), Mendelian randomization (MR), and colocalization were applied to evaluate causal links. Functional significance was assessed through GeneMANIA, drug enrichment, and molecular docking analyses.

Results

Three ALD susceptibility genes—AFF1, C4orf36, and HSD17B13—were identified and validated. HSD17B13 may reduce ALD risk via lipid metabolism and redox balance, while AFF1 is implicated in transcription regulation. C4orf36 requires further study. Drug enrichment analysis highlighted AFF1 as a target for beta-D-allopyranose, dexbrompheniramine, and (+)-chelidonine, with molecular docking confirming strong binding potential.

Conclusion

This study identifies AFF1, C4orf36, and HSD17B13 as ALD susceptibility genes, proposing AFF1 as a potential therapeutic target, paving the way for precision medicine in ALD, though further experimental validation is needed to establish their functional relevance.

Schlagwörter

Stichwörter der Autor:innen

Mendelian randomization (MR)alcohol- associated liver disease (ALD)drug enrichment analysisgenome-wide association study (GWAS)multi-marker analysis of GenoMic annotation (MAGMA)transcriptome-wide association study (TWAS)

Autor:innen und Institutionen

  • Graduate School, Shandong First Medical University, Jinan, Shandong, China.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Zitieren

APA

Wang, Q., Wang, Z., Hu, M., Liu, F., & Wang, Z. (2025). Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1623367

Vancouver

Wang Q, Wang Z, Hu M, Liu F, Wang Z. Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1623367

BibTeX
@article{Wang2025,
  author = {Wang, Qianchang and Wang, Zhe and Hu, Minzhe and Liu, Fangfeng and Wang, Zhengjian},
  title = {Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes},
  journal = {Frontiers in Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fmed.2025.1623367}
}
Kostenlos starten →